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Introduction
For many children, hypertension is only diagnosed when 
it is severe, or once they reach adulthood. However, the 
importance of early and accurate diagnosis cannot be 
overstated, given the long-term health consequences of 
untreated hypertension and the fact that pediatric hyper-
tension is a diagnostic indicator for some serious under-
lying medical conditions. For the purposes of this article, 
the words pediatric and youth refer to both children 
(aged 2-18 years) and adolescents (aged 13-18 years).
Obesity has been posited as the cause of hypertension, 
but the fact that there are metabolically obese normal 
weight (MONW) people, as well as overweight and 
obese people who are metabolically normal, would argue 
that there may not be a simple cause-and-effect relation-
ship between them. The fact that they can appear inde-
pendently as well as together would indicate that they 
might both be signs that something has gone wrong met-
abolically, and therefore perhaps both of them are effects. 
Moreover, the obesity and hypertension epidemics have 
arisen concurrently with significant changes in family 
structures that have resulted in increased consumption of 
fast foods and prepared foods, and therefore sodium, 
trans-fats, and high-fructose corn syrup, as well as more 
automation of activities that formerly required physical 
labor to accomplish, and a more fast-paced and deadline-
driven environment in almost every facet of life.
This literature review (a) examines the various fac-
tors that contribute to hypertension in adolescents as 
illustrated in Figure 1, (b) summarizes the findings of 
researchers in various disciplines who are studying these 
factors, and (c) identifies the barriers to progress and the 
interventions that have been proposed by them.
The Challenges of Blood Pressure 
Classification
Diagnosing Pediatric Hypertension
Untreated pediatric hypertension has long-term serious 
health consequences. Sustained hypertension in children 
is often caused by a serious underlying health problem 
affecting the heart, kidneys, or endocrine system.1-3 This 
type of hypertension is known as secondary hyperten-
sion, because it develops due to the medical condition. 
Mild to moderate hypertension with no known underly-
ing disease process is classified as primary or essential 
hypertension. This is the type of hypertension that many 
older children and most adults have. In children with 
hypertension, 30% to 60% have secondary hyperten-
sion, while 40% to 70% have primary hypertension.4 In 
children, the prevalence of hypertension is estimated at 
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between 2% and 5%, and the prevalence of prehyperten-
sion is estimated at between 4% and 15%,5,6 but studies 
in both the United States and Europe have found that 
only 13% to 26% of childhood hypertension is properly 
diagnosed.1,2,7-9 Children with primary hypertension 
may be asymptomatic or the symptoms may be mild and 
seemingly unrelated, such as changes in behavior or 
school performance, nosebleeds, headaches, or short-
ness of breath.10
The upper limit for “normal” blood pressure (BP) in 
adults is well known, and the same threshold is used for 
both men and women: the systolic blood pressure (SBP) 
should be less than 140 mm Hg, and the diastolic blood 
pressure (DBP) should be less than 90 mm Hg. A diag-
nosis of high BP in children aged 3 to 18 is more chal-
lenging, because children grow so rapidly and BP 
changes with height. Standardized height-for-age tables 
have been developed for children,11 based on gender, 
with different thresholds for every combination of 
incremental age and height. This height percentile is 
then used to determine where SBP or DBP falls within 
given BP percentiles for healthy children of the same 
age and gender.12 When a valid office blood pressure 
(OBP) reading is taken (using the correct cuff size and 
a calibrated device, by a properly trained professional) 
but the height of the child is not measured on the same 
visit, the practitioner cannot use the reference tables to 
determine whether that reading places the child in an 
elevated risk category.
The standardized tables are quite cumbersome and 
time-consuming and there are too many data points to 
memorize “normal” parameters. Therefore, attempts 
have been made8,9 to enable rapid preliminary assess-
ment of possible prehypertension or hypertension by 
simplifying the diagnostic process, but it is not clear 
how widely these tables are used. In addition, there 
are different parameters for different nationalities and 
ethnicities,3,9,13 which further complicates diagnostic 
efforts. Clearly, without the use of reference tables of 
some kind it is virtually impossible to correctly iden-
tify hypertension in most children unless it is signifi-
cantly elevated.
In children, prehypertension is persistent BP that 
equals or exceeds the 90th percentile for a normotensive 
child of the same age, sex, and height, or is below the 
95th percentile but exceeds 120/80 mm Hg (either SBP 
Figure 1. The many interrelated factors that influence hypertension in adolescents, and some of the serious consequences 
that result from delayed diagnosis and treatment.
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exceeds 120 mm Hg, or DBP exceeds 80 mm Hg, or 
both). Hypertension is persistent BP that equals or 
exceeds the 95th percentile for a normotensive child of 
the same age, sex, and height.12 Documentation of ele-
vated BP readings at 3 or more well-child visits has been 
found to greatly improve the chances of a correct diag-
nosis, by nearly double for children with hypertension, 
and more than triple for those with prehypertension.2 
With repeated testing, one study found that approxi-
mately 9% of adolescents had a change in BP classifica-
tion, with 6.2% decreasing from prehypertension to 
normotensive, and 2.9% increasing from prehyperten-
sion to hypertension.14
Failure to recognize elevated BP occurs most fre-
quently when the patient’s SBP and DBP are less than 
the adult thresholds, the patient appears to be of normal 
weight for their height, and there is no family history 
of cardiovascular disease (CVD).2,7 One study found 
that the children most often missed were those who 
were older, male, and/or those whose BP was taken by 
nurse-practitioners or less experienced providers.7 
Only 13% of children with elevated BP in this study 
were actually diagnosed, and the children with the low-
est rate of recognition—just 7%—were those of healthy 
weight. Another study reported that just 11% of prehy-
pertensive and 26% of hypertensive children were 
diagnosed, even when their health record included a 
positive family history of hypertension.2
These results are consistent with another study,1 
which found that only 25% of pediatric physicians rou-
tinely measured BP in their patients, while 71% mea-
sured it only when risk factors for hypertension were 
present, such as obesity or positive family history of 
hypertension. Of those who measured BP, 65% did not 
use the reference tables unless they suspected the BP 
reading was elevated. However, of the pediatric physi-
cians in this study, 14% could not correctly define pre-
hypertension and 17% could not correctly define 
hypertension in children. Perhaps not surprisingly, a full 
47% of pediatricians who participated in this study 
underestimated the BP category of patients when pre-
sented with pediatric case studies.
Both United States and European guidelines recom-
mend obtaining BP readings at each well-child visit,3,12 
and studies have shown that repeated BP measurements 
are an effective way to ensure proper classification and 
tracking of BP in children.10,14 Despite this, some claim 
that individual variability makes screening for elevated BP 
a less-than-useful tool for predicting CVD,15 and that there 
is insufficient evidence to determine whether BP screening 
in asymptomatic children is harmful or beneficial.16
Among those who advocate for diagnostic screening, 
there is debate about the best method for monitoring BP 
in children. Ambulatory blood pressure (ABP) monitor-
ing has been proposed by some17,18 as a better gauge 
than OBP of whether the patient’s BP warrants concern. 
Rather than a health care professional taking a one-time 
measurement during what can be a stressful experience 
in an unfamiliar environment, which can lead to an 
incorrect diagnosis of hypertension due to “white-coat” 
effect, ABP monitors are worn for 24 hours and periodi-
cally measure BP during that time. These results are then 
analyzed for overall cardiovascular impact.
Although ABP monitoring in children may reduce 
“white-coat” hypertension diagnoses, it is not without 
its own complexities and limitations. A 2004 review of 
several ABP studies expressed concerns about the valid-
ity of reference data for children, the lack of monitors 
specifically designed for children, and the relative lack 
of familiarity with interpreting the many data points 
generated during ABP monitoring.19 However, this 
review also noted that recent and ongoing studies were 
addressing these issues and pointed out the usefulness 
and benefits of ABP monitoring in some research set-
tings. The American Heart Association also affirmed the 
benefits of ABP monitoring as a diagnostic tool, but 
emphasized that it should be done by trained staff and 
experts in pediatric hypertension.12
ABP monitoring plays a crucial role in the diagnosis 
of persistent masked hypertension, which cannot be 
diagnosed by conventional BP measurements alone. 
Persistent masked hypertension is diagnosed when 2 or 
more ABP readings are hypertensive but conventional 
BP readings are normotensive. ABP monitoring has 
revealed that the prevalence of persistent masked hyper-
tension is between 10.9% and 14% in adults, and is asso-
ciated with increased risk of developing sustained 
hypertension and type 2 diabetes mellitus (T2DM), 
organ damage, and CVD. Children who have hyperten-
sive parents or a family history of hypertension are at 
high risk for developing these same conditions and 
should have ABP monitoring for proper diagnosis and 
early treatment.20
One 2013 retrospective study21 found that using 
24-hour mean arterial pressure (MAP), which is recorded 
by ABP monitoring devices, increased the number of 
hypertension diagnoses. MAP is calculated by taking one 
third of the difference between SBP and DBP and adding 
it to DBP; this is seen as a measure of the effect of BP on 
the cardiovascular system over time.17 Another 2013 ret-
rospective study22 found that daytime ABP tends to be 
higher than OBP in children (especially younger chil-
dren) and can result in incorrectly classifying them as 
hypertensive. The authors’ recommendation was to con-
tinue using OBP in clinical practice until more research 
has been done and the results have been reviewed.
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These academic disagreements about the need for 
and usefulness of pediatric BP screening and the best 
method for obtaining reliable data, plus the failure to 
consistently use reference tables to interpret the readings 
that are obtained, likely contribute to the low diagnostic 
rates noted previously. However, in contrast to obesity 
screening, hypertensive screening cannot be done sim-
ply by looking at the children, so pediatric health care 
providers should follow the consensus guidelines for 
measuring and documenting BP percentile at every visit. 
Without this information, an important diagnostic and 
predictive tool is lost.
Causes of Hypertension
The degree of persistent hypertension, the age of the 
child, the symptoms found during physical examination, 
and the risk factors documented in a thorough patient 
history will determine the next steps taken by the physi-
cian. For example, a child with low birth weight, family 
history of hypertension, and/or obesity has an increased 
probability of developing pediatric hypertension.2 
Undiagnosed hypertension results in measurable organ 
damage in children, and overweight and obese children 
have a significantly increased risk of developing hyper-
tension as adults.23
Risk factors for hypertension that cannot be modified 
include a family history of hypertension or CVD,12 low 
birth weight, gender, race, genetic inheritance, socioeco-
nomic status (SES), premature birth,10 and use of umbil-
ical artery catheters.24 Risk factors that can be modified 
include decongestants, nose/eye drops, oral contracep-
tives, (OC) antidepressants, bronchodilators,24 dietary 
habits, salt intake, excess adiposity, physical activity 
level, secondhand smoke, and poor sleep quality and/or 
short sleep duration.10
Sleep-disordered breathing (SDB) and obstructive 
sleep apnea (OSA) have both been associated with 
pediatric hypertension25 and should be ruled out or 
treated. The prevalence of OSA in all children is esti-
mated at less than 3%, but estimates in obese youth 
range from 5.7% to 36%, with prevalence and severity 
positively correlated with the degree of obesity.26 The 
risk of SDB in general increases by 12% for every 1 kg/
m2 above mean body mass index (BMI), and for each 
standard deviation above mean BMI, the risk of OSA is 
3.5-fold greater.26
Typically, older children and adolescents are more 
likely to present with primary hypertension, while 
younger children are most likely to have secondary 
hypertension.2,10,16 Low renin and abnormal sodium 
transport in the kidneys are characteristics of secondary 
hypertension with an underlying genetic basis, which 
should be further investigated.3 For all children with 
persistent elevated BP, a baseline evaluation to exclude 
secondary causes should include certain blood and urine 
tests, a kidney ultrasound, and an echocardiogram.25 If 
these are found to be abnormal, the child should be 
referred to a pediatric nephrologist or pediatric cardiolo-
gist for further evaluation; if the baseline evaluation is 
normal and no medical condition has been found, pri-
mary hypertension is diagnosed.25
Hypertension Is Highly Correlated With 
Overweight and Obesity
Although not all overweight or obese people develop 
hypertension, weight gain is usually associated with a 
corresponding increase in BP.27 It is widely recognized 
that overweight and obesity are closely associated with 
hypertension in children.10,28,29 The prevalence of pedi-
atric hypertension is estimated to be 3% to 14% for nor-
mal weight children and 11% to 30% for obese 
children.30 The degree of overweight or obesity and 
hypertension manifested during childhood directly cor-
relates with the risk of developing hypertension, stroke 
or other CVD, and kidney disease in adulthood.10,31 
Childhood obesity rates have risen alarmingly during 
recent decades, and not surprisingly, rates of childhood 
hypertension and T2DM have risen right along with 
them. Since each of these conditions can exist indepen-
dently of the other 2 conditions and cannot be accu-
rately diagnosed by a child’s appearance alone, these 
conditions must be screened for on a regular basis by 
the child’s healthcare provider.
Studies have found that most physicians can diag-
nose moderate to severe obesity simply by the appear-
ance of their patients, but they are less likely to visually 
identify overweight children32-34 thus, overweight chil-
dren are at high risk of progressing to obesity before 
being diagnosed. BMI is recommended as an objective 
way to estimate the relative degree of adiposity based on 
weight and height (kg/m2), and its documentation is rec-
ommended at least once per year35 or at every well-child 
visit.32 Repeated BMI documentation has been shown to 
increase both rates of overweight diagnosis and obesity 
prevention efforts.32-36
Again, as with pediatric BP tracking, compliance 
with the consensus guidelines for BMI tracking has been 
inconsistent. One survey found that 72% of surveyed 
pediatricians indicated they were not familiar with BMI 
recommendations, 91% of those physicians relied on 
visual assessment to diagnose overweight, and BMI per-
centile was calculated in just 52% of patients aged 3 or 
older.36 Another survey of United States pediatric pro-
viders found that just 31% could correctly define both 
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overweight and obesity in children, while only 46% rou-
tinely calculated BMI and only 43% made a correct 
visual diagnosis of overweight and obese children.34 
These findings are consistent with other surveys of pedi-
atricians, which found that 86% of obese patients but 
only 27% of overweight patients were diagnosed,33 and 
that 31% of surveyed physicians said they never used 
BMI while only 11% said they always did.37
Part of the resistance to BMI tracking is that it must 
be calculated from weight and height and, as with BP, 
“normal” BMI in children changes with gender and age. 
Reference tables must therefore be used to determine the 
BMI percentile for each child. In addition, “normal” 
BMI is different for each nationality and ethnicity.29,38 
For children aged 5 to 17, age-, sex-, and race-specific 
BMI percentile tables have been published,38 and at least 
4 different reference tables are in common use.11,29,39 
The reference table that is used matters, because chil-
dren are classified as underweight, healthy weight, over-
weight, or obese based on their BMI percentile. Since 
BMI calculation is time-consuming, a simplified table 
has been published40 that uses just height and weight to 
identify children requiring actual BMI calculation, but it 
is not known how widely it is used. Even with electronic 
medical records that automatically calculate BMI per-
centiles, unless practitioners regularly incorporate these 
results into their screening practices, overweight chil-
dren will continue to be underdiagnosed, and obesity 
prevention efforts will continue to be hampered.
With that said, however, BMI by itself does not accu-
rately indicate body composition, that is, the “fatness” 
or adiposity of a child. BMI is intended to estimate 
excess adiposity (not excess weight) in those who are 
presumed to have a normal amount of lean body mass.35 
Calculated BMI does not directly measure the actual 
muscle mass or amount of fat in an individual, which 
can result in misclassification of those who are very 
muscular.32 An athlete with a high percentage of muscle 
mass and very low body fat percentage could be classi-
fied as obese based strictly on BMI percentage.
In addition, children with low birth weight have 
reduced lean muscle mass when they are younger and an 
increased risk of abdominal adiposity when they grow 
older.41 Research has shown that children who become 
obese in infancy are generally taller than average as they 
mature,41 while those who have excess adiposity are 
generally taller than other children of the same sex and 
age.42 Clearly, there is not a one-for-one relationship 
between height and adiposity in children, and variation 
in degree of fatness is more common than variation in 
height.41 Because of these issues, researchers have 
explored ways to derive a height-adjusted adiposity 
index that removes this relationship.41,43
From the 2007 Expert Committee recommendations 
for children,32 an age- and gender-specific BMI below 
the 5th percentile is considered underweight, and a BMI 
at or above the 85th percentile but less than the 95th 
percentile is classified as overweight. Healthy weight is 
defined as a BMI that falls at or above the 5th percentile 
but less than the 85th percentile, while the threshold for 
obesity is either a BMI greater than or equal to the 95th 
percentile, or a BMI greater than or equal to 30 kg/m2, 
whichever is lower. In recognition of the greater medical 
risks faced by those with extreme obesity, the Expert 
Committee also proposed an additional category of 
severe obesity for children at or above the 99th percen-
tile. This equates to a BMI of between 30 and 32 kg/m2 
for children 10 to 12 years old or a BMI of at least 34 kg/
m2 for children 14 to 16 years old. The American Heart 
Association26 defines severe obesity as an absolute BMI 
greater than or equal to 35 kg/m2, or greater than or 
equal to 120% of the 95th percentile, whichever is lower 
based on age and sex.
The American Academy of Pediatrics estimates that 
the risk of childhood obesity continuing into adulthood 
increases from about 20% at age 4 to about 80% by ado-
lescence, and is associated with medical problems that 
affect cardiovascular, endocrine, and mental health, in 
addition to pulmonary, orthopedic, hepatic, and gastroin-
testinal complications.35 Severe obesity is more prevalent 
in those with lower SES and in Hispanic, Mexican-
American (MA), non-Hispanic Black (NHB), and Native 
American (NA) youth.26,32 Severe obesity is the fastest-
growing classification of obesity, with 4% to 6% of chil-
dren and adolescents in the United States having a BMI in 
the severe obesity category.26
Among adolescents in the highest BMI quintile, 
non-Hispanic Whites (NHW) had the highest DBP and 
rates of hypertension, but at all other BMI quintiles, 
there were greater rates of high DBP and hypertension 
in NHB. In all BMI quintiles, SBP was higher for 
NHW than for NHB, except for older girls, where the 
opposite relationship was found. In adolescent males, 
BMI had a significantly greater influence on SBP in 
NHW than in NHB.44 A multiethnic study30 found that 
higher waist circumference (WC) in NHB and NHW 
children was significantly associated with a higher BP 
classification, but Hispanic children, who had the high-
est measurements of WC, BMI percentile, and fat 
mass, had the lowest BP classification. NHB racial 
heritage was independently associated with hyperten-
sion; more NHB children were found to have prehyper-
tension or hypertension when compared to Hispanic 
and NHW children, and although NHB children had 
less body fat and lower BMI than Hispanic children, 
nearly 20% had elevated BP.30
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In addition to genetic causes, such as Prader-Willi 
syndrome, Bardet-Biedl syndrome, and Cohen syn-
drome, risk factors for childhood obesity include high 
birth weight, maternal diabetes, a family history of obe-
sity, families with migration background, formula feed-
ing during infancy, eating disorders, racial/ethnic 
predisposition, low physical activity, high television/
computer usage, low income, poor diet, and depression 
or anxiety.32,35,45 Risk of obesity and hypertension are 
inversely related to the extent and duration of breast-
feeding and to SES,10,35 and risk of obesity is possibly 
influenced by food insecurity.35
Excess adiposity is the single most powerful risk fac-
tor for higher BP and contributes to more than half of the 
risk for developing hypertension.3 However, since body 
composition changes rapidly during adolescence, an 
increase in BMI should not automatically be interpreted 
as an indication of increased adiposity. Increased muscle 
mass is the primary driver of the increases in BMI which 
occur in boys between the ages of 12 and 17 years and in 
girls between the ages of 10 and 16 years.42 In addition, 
care must be taken to distinguish adolescents who have 
a larger BMI due to excess adiposity from those who are 
tall for their age and therefore may have a larger BMI 
due to stature.30,42 Likewise, the degree of adiposity may 
be underestimated in those who are at the lower height 
percentiles.30
Several studies have shown that adiposity change in a 
child over time can best be measured by using actual 
BMI (kg/m2) or BMI (%) units instead of BMI centiles or 
z-scores.38,46,47 BMI distribution is skewed in the higher 
and lower centiles of BMI tables, because the centile 
curves are farther apart; in effect, the tails of the distribu-
tion are biased relative to the median.26,47 Z-scores are 
best for standardizing one-time measurements across a 
population, but are not designed to measure within-child 
changes in adiposity over time.47 In an overweight or 
obese child, actual BMI (kg/m2) or BMI (%) units tracked 
over time will identify whether that child is remaining in 
the same percentile category or crossing percentile 
categories.38,47
Hypertension and the Adiposity Effect
An accurate assessment of adiposity is very important 
when determining hypertensive status. A recent study23 
evaluated the effect of adiposity on BP in overweight 
and obese children and found that when the BMI 
exceeded the 85th percentile, 14% of overweight and 
obese children had BP measurements in the prehyper-
tensive or hypertensive range. In contrast, just 5% of 
normal weight children had BP above the normotensive 
range. This study also looked at the adiposity effect by 
race and gender and found that overweight NHB females 
had a 33% increase in risk of elevated BP for every 5% 
increase in BMI percentile; for every other group, the 
risk was nearly doubled for every 5% increase in BMI 
percentile. The intensification of risk was observed in all 
race and sex groupings and was similar for all ages of 
the children in the study.23
Importantly, for children with a BMI over the 85th per-
centile, the effect of BMI percentile on BP was 4 to 5 
times greater than for children with a BMI below the 85th 
percentile, and for children with a BMI over the 90th per-
centile, the effect on BP was more than 6-fold.23 These 
findings are significant because they show that elevated 
BP in children is directly correlated with the degree of 
adiposity, and the effect on BP escalates dramatically as 
the degree of adiposity increases. This study echoes the 
findings from an earlier study,31 which reported a greater 
than 4-fold increased risk of future elevated BP when 
childhood adiposity was above the 85th percentile. 
However, the more recent study found that elevated BP 
due to the adiposity effect is not just a future risk once 
adulthood is reached, but exists as a clear and present risk 
during childhood.23
Hypertension, Metabolic Syndrome, and CVD
There is strong evidence that elevated BMI during ado-
lescence, even within the normal BMI range, is associ-
ated with increased risk of developing hypertension and/
or CVD as an adult.48-51 Elevated BMI in both adoles-
cence and young adulthood is significantly and indepen-
dently associated with the risk of developing CVD and 
is predictive for it; there is a 12% increase in risk of 
CVD for every 1-unit increase in adolescent BMI.51 
Future risk of hypertension can be predicted indepen-
dently by either BMI at age 17 or BP at age 17, and 
males have a 3- to 4-fold higher risk than females,51 
while the risk of hypertension is higher for obese adults 
who were overweight or obese as children than for those 
who had normal weight as children.49 One study of chil-
dren and adolescents found that 35.6% with elevated BP 
still had elevated BP 6 years later, nearly 20% of those 
who had been normotensive crossed into an elevated BP 
category during that time, and an increase in BMI was 
correlated with a change in BP classification from nor-
motensive to a higher category.52
Unfortunately, adiposity as measured by BMI does 
not indicate the distribution of fat, that is, overall sub-
cutaneous fat, centralized abdominal or visceral fat, or 
a combination of both.27 Visceral fat has different met-
abolic characteristics from subcutaneous fat, and those 
with centralized obesity are at greater risk of develop-
ing hypertension, insulin resistance (IR), dyslipidemia, 
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atherosclerosis or other CVD, and inflammatory 
responses.27,28 The World Health Organization defines 
centralized obesity as WC greater than the 75th percen-
tile or a waist-to-height ratio greater than or equal to 
50%.29 Although the 2007 Expert Committee recom-
mended using BMI as a measure of adiposity in chil-
dren, it did not recommend using WC as a predictor of 
CVD risk because no reference values were available 
for children.32 However, reference tables have been 
published for children of varying ethnicities and 
nationalities.53-56
Recent research suggests that WC should be used 
along with BMI because it is a reliable measure of vis-
ceral adiposity in children and can therefore indicate 
associated conditions that may be otherwise over-
looked. In children with normal BMI, larger WC has 
been found to be a predictor of increased risk for hyper-
tension.28,57 An evaluation of the relationship between 
measures of fatness (BMI, fat mass, and WC) and strati-
fication of BP (normotensive, prehypertensive, and 
hypertensive) in children found that when these mea-
sures were adjusted for height, only central adiposity 
and WC were positively associated with elevated BP.30 
In adults and children who are overweight or obese, 
WC as a measure of centralized obesity is highly cor-
related with increased risk for hypertension, CVD, and 
metabolic syndrome (MetS).27,57
Metabolic syndrome is the name used to describe a 
combination of hypertension, abdominal obesity, dys-
lipidemia, glucose intolerance and/or IR, and proin-
flammatory or prothrombotic states.58 When 3 or more 
of these conditions occur together, a diagnosis of MetS 
is made.59 Another term for this constellation is meta-
bolically obese. It is important to distinguish between 
metabolic obesity and physical obesity, because studies 
have consistently reported that MONW people are quite 
common.60,61
A recent study of generalized, centralized, and com-
bined adiposity distribution in children found that some 
overweight and obese children are metabolically normal 
and some children are MONW.57 This study reported 
that CVD risk factors such as MetS, dyslipidemia, and 
hypertension were highest in children with combined 
visceral and subcutaneous adiposity, lower in children 
with just centralized adiposity, and lowest in children 
with generalized subcutaneous adiposity. Children who 
were physically obese but metabolically normal were 
most often found to have generalized fat distribution but 
not centralized or visceral adiposity.
In tandem with obesity rates, the prevalence of MetS 
is rising among children and adolescents,59 but there is 
not always a one-for-one correlation between MetS and 
adiposity. MetS develops in some children who are of 
normal weight, while some overweight and obese chil-
dren do not develop it.57,59 MetS is a risk factor for 
developing CVD and/or T2DM.59 Pediatric patients 
with T2DM may not have symptoms; risk factors include 
family history of diabetes, NHB, Hispanic, or NA heri-
tage, and BMI at or above the 85th percentile.32 The dis-
tribution of adiposity is therefore a critical factor in the 
development (or not) of dyslipidemia, hypertension, and 
MetS.27,57
In addition to the type of adiposity, ethnicity and 
gender are also factors that need to be considered 
when assessing risk of developing MetS with its asso-
ciated cardiovascular effects. For example, when com-
pared to NHW children, NHB and Hispanic children 
have a higher frequency of IR, and South Asian and 
Middle Eastern children have a higher prevalence of 
MetS.59 Studies have found that WC predicts and is 
significantly correlated with IR,62 hypertension, and 
dyslipidemia63 in children with excess abdominal fat, 
independent of race or BMI percentile. WC may be 
particularly relevant as a predictor of MetS in non-
Hispanic Asian (NHA) children, since several studies 
have found this ethnicity to have higher visceral adi-
posity despite lower obesity.64-66
A study in China found that 15.5% of normal weight 
boys and 18.8% of normal weight girls had MetS, while 
63.1% of normal weight adolescents had at least one 
marker for CVD.67 Among normal weight, overweight, 
and obese children in this study, the prevalence of MetS 
was found to be 1.5%, 18.3%, and 38.1%, respectively.67 
In contrast, a similar study of NHB, NHW, and MA chil-
dren in the United States reported that the prevalence of 
MetS among normal weight, overweight, and obese sub-
jects was just 0.1%, 6.8%, and 28.7%, respectively.68 It 
is therefore important for all children to be regularly 
screened for high BP, dyslipidemia, and altered glucose 
metabolism, regardless of their weight status.
In addition to serious long-term health consequences 
from delayed diagnosis and treatment of hypertension, 
obese adolescents often experience discriminatory behav-
ior, leading to social and economic consequences later in 
life.69 Unfortunately, disadvantaged youth are most at risk 
for these consequences, partly due to socioeconomic fac-
tors, partly because of psychosocial stressors that are 
unique to this population, and partly from racial or ethnic-
ity predispositions.
Confounding Influences
Ethnicity/Racial/Socioeconomic Influences
Retrospective analyses of several longitudinal stud-
ies44,69,70 found distinct racial and ethnic differences 
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among adolescents. NHB boys had lower obesity rates 
than Hispanic or NHW boys, but adolescent boys were 
generally more likely to be obese than girls, except 
among NHB, where obesity was more prevalent in girls. 
Hispanic adolescents had a greater probability of higher 
WC, and experienced increased obesity rates over time. 
Among Hispanic adolescents of both genders, obesity 
was highest among Puerto Ricans and MA, whereas 
Central and South American youth and Cuban American 
females had much lower obesity rates. Among NHA, 
Chinese and Filipinos had the lowest obesity rates, while 
Korean, Japanese, Southeast Asian, and Indian-
American adolescents were most likely to be over-
weight. NHW had lower obesity rates than all other 
adolescent groups except Chinese and Filipino youth. 
The highest rates of adolescent obesity were found 
among NHB females, Hispanic males, and NHA who 
were neither Chinese nor Filipino, and among NA youth, 
who had significantly higher obesity rates than all other 
adolescent groups.69,70
First-generation NHA and Hispanics who were not 
born in the United States had lower obesity levels than 
children born to immigrant parents in the United States. 
Except for Chinese-Americans, both NHA and Hispanics 
experienced significant changes in obesity levels 
between the first and second generations. Second- and 
third-generation Hispanic youth were more likely to be 
obese than first-generation adolescents, while NHA girls 
were considerably less likely to be obese, although the 
obesity level for second-generation NHA youth more 
than doubled from first-generation adolescents.69 
Hypertension rates were found to be lower in Central 
and South American first-generation, less acculturated 
Hispanic immigrants than in NHW and NHB, regardless 
of WC or body weight, and BP was lower in first-gener-
ation compared to second-generation MA.30
Racial heritage is clearly a factor in obesity-related dis-
ease outcomes; however, diseases classified by race should 
not be confounded with diseases classified by ethnicity. 
Ethnicity incorporates cultural aspects, such as diet, reli-
gion, and language, as well as genetics. Ethnic heritage is 
modified by socioeconomic conditions and lifestyle adap-
tations driven by the geographic region of the world where 
a person lives. Similar ethnic groups in different geographic 
locations may therefore have very different disease rates 
and risk factors.71 There may also be a physiological factor 
in how psychosocial stressors affect people of different 
races; those who have a vascular response (α-adrenergic) 
may eventually develop hypertension, while those who 
have a cardiac response (β-adrenergic) may be more 
affected by atherosclerosis.72
The leading cause of death in Hispanics is CVD (28% 
in males, 34% in females),73 but NHB and NHW have 
higher rates of death from cardiovascular events and 
higher rates of death from all causes than Hispanics. The 
tendency toward obesity and T2DM is similar in 
Hispanics and NHB, while obesity rates and IR are sig-
nificantly different between NHW and Hispanics. NHB 
have higher risks for hypertension and certain obesity-
related cancers and higher rates of prostate cancer, while 
Hispanics have higher risk of fatty liver disease and 
lower rates of some chronic illnesses, despite the fact 
that many experience lower SES.70
Lower childhood SES has been correlated with 
smaller decreases in nighttime BP, called nocturnal non-
dipping, both in adolescence and in adulthood and may 
contribute to risk of developing CVD or hypertension 
later in life.72,74 Studies have shown that in adolescents, 
BP nondipping is negatively associated with childhood 
SES but is not associated with BMI,72,74 and BP nondip-
ping is more prevalent in NHB and low SES adults.72 
Nocturnal nondipping has been associated with organ 
damage and is thought to be more frequent among those 
with posttraumatic stress disorder,74 and those with 
greater chronic stress or negative emotions,72,74 and 
often occurs before sustained hypertension develops.24 
Some of the racial differences in nocturnal nondipping 
may be due to the greater psychosocial stressors that are 
concurrent with low SES, which disproportionately 
affects immigrant and minority populations.
Psychosocial and Mental Health Influences
Research has shown a relationship between childhood 
overweight/obesity and psychosocial stressors such as 
migration background, SES, parental discord or divorce, 
domestic violence, child abuse, and chronic physical or 
mental health conditions of family members.45,75 These 
factors have been found to be more predominant in low-
income, immigrant, and minority youth, and to have a 
significant negative influence on the outcome of weight 
loss programs.45,75 In addition to psychosocial stressors, 
mental health issues significantly influence whether dis-
advantaged youth are overweight or obese, and whether 
they are successful at weight loss efforts.
Depression in disadvantaged youth is highly corre-
lated with increased likelihood of overweight or obe-
sity.75 Compared to their normal weight peers, 
overweight and obese children experience greater 
depression, suicidal thoughts, feelings of worthlessness 
or hopelessness, anxiety, body dissatisfaction, and poor 
academic performance.76 Obese children are perceived 
as lazy, unhealthy, unhygienic, socially inept, and aca-
demically unsuccessful, and these stereotypes result in 
low self-esteem, sadness, loneliness, social isolation, 
and high-risk behaviors, all of which contribute to 
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significantly reduced quality of life.77 It is not clear 
which of these factors contribute to, and which are con-
sequences of, obesity.
A 10-year study of adolescent girls,78 which evalu-
ated the most important factors for predicting future 
changes in BMI and onset of overweight or obesity, 
found that income and race/ethnicity were two of the 
most important independent predictors for weight gain, 
onset of overweight, and BMI percentile change, with 
NHB and low SES adolescents being most affected. 
BMI percentile change was predicted by body dissatis-
faction and drive for thinness, which includes excessive 
dietary restraint. These psychological traits have been 
associated with a greater increase in BMI, possibly due 
to extreme dieting or skipping meals followed by over-
eating or binge eating/bulimia.78
In contrast, onset of overweight and obesity was pre-
dicted by the psychological traits of perfectionism, 
emotional eating, ineffectiveness, and interoceptive 
awareness, which is the ability to distinguish between 
hunger and satiety, to be aware of bodily sensations, 
and to identify and be aware of feelings. Feelings of 
worthlessness, inadequacy, insecurity, and lack of con-
trol over life are components of ineffectiveness. These 
psychological factors, taken together, comprise self-
regulatory skills; if these are poorly developed, com-
pensatory overeating may occur, especially if negative 
emotions are involved.78
School-based programs using cognitive behavioral 
therapy have been found to be an effective means of 
addressing some of these mental health issues. In one 
study, participants not only lost weight but also 
reduced their degree of anxiety and/or depression and 
increased their commitment to make healthy lifestyle 
choices.76 Another behavioral weight control program 
for obese adolescents, which combined dietary modi-
fication, prescribed group physical activity, and inten-
sive behavior modification therapy for the adolescents 
along with parental support therapy, resulted in sig-
nificant weight loss and improvements in self-concept 
and self-confidence; a 2-year follow-up study with the 
original participants found that the improvement in 
self-efficacy from the initial intervention was sus-
tained over a 24-month period.79
In addition to the inherent and perhaps unfamiliar 
challenges of losing weight, adolescents are simultane-
ously navigating the new and complex factors of 
increasing peer pressure, more autonomy from parental 
influences, and physiological changes due to pubertal 
hormones. Pubertal stage is an important and often 
overlooked factor that is unique to adolescence, and it 
must be considered when evaluating adiposity and 
hypertension in adolescents.
Gender and Pubertal Influences
A well-designed study80 reported that BMI as a measure 
of adiposity is not independent from pubertal stage, 
race, gender, or waist/hip ratio, and that the same BMI 
percentile does not in any way indicate differences in 
percentage of body fat by distribution (peripheral vs 
central adiposity), between girls and boys (girls have 
more), or between races (NHW have more than NHB). 
This study found that pubertal stage is significantly and 
more closely correlated than age with BMI; that adoles-
cents who have reached puberty have a lower body fat 
percentage than prepubertal adolescents of the same 
BMI; and that those with central adiposity may have a 
lower BMI despite having a greater percentage of body 
fat than those with overall subcutaneous fat.80
Research has also shown that the pubertal growth 
spurt occurs earlier for girls than for boys; that it is sig-
nificantly associated with increases in SBP and DBP in 
both genders; that BP increases more rapidly during the 
growth spurt than before or after it; and that boys have a 
significantly greater increase in BP than girls.81,82 These 
studies used height as a proxy for timing the pubertal 
growth spurt and reported that the peak of increase in BP 
coincided with the peak in acceleration of height. The 
pubertal growth spurt lasted about 4.5 to 5 years, with 
onset approximately 3 years before the peak in height 
acceleration and BP was reached. During this growth 
spurt, SBP and DBP increased significantly, but SBP 
increased significantly more in boys than in girls, while 
DBP increased more in girls than in boys.81,82
During pubertal growth, mean SBP was noticeably 
higher in boys than girls (107.2 vs 99.2 mm Hg), and of 
note, the mean age at which pubertal growth peaked in 
NHB youth was 6 to 11 months sooner than for NHW 
youth, suggesting that at all chronological ages, NHB 
adolescents may have higher BP than NHW adoles-
cents.82 During the pubertal growth spurt in NHB youth, 
there was also a greater increase in SBP if one parent 
had hypertension than if both parents had normal BP.81 
The gender difference in BP continues after puberty as 
well; in a study of 17 year olds, mean SBP was higher in 
boys than girls (117.9 vs 108.6 mm Hg), the prevalence 
of prehypertension was 36% for boys and 8.9% for girls, 
while the prevalence of hypertension was 2.2% for boys 
and 0.3% for girls.83
In a large, prospective, multiyear study20 that assessed 
the presence or absence of masked hypertension at base-
line, when compared with normotensive participants, 
children with masked hypertension had significantly 
higher ABP and conventional BP, and boys (but not girls) 
more frequently had a parental history of hypertension. 
There were significant differences during follow-up 
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between boys and girls with masked hypertension: both 
were more likely to develop sustained hypertension, but 
the rates were astonishingly different: 17.4% versus 
0.8% of girls, and 50.0% versus 1.9% of boys, respec-
tively, when compared to normotensive subjects. In addi-
tion, 23.1% of girls and 6.2% of boys maintained masked 
hypertension, while 56.5% of girls and 37.5% of boys 
reverted from masked hypertension to normal BP during 
the follow-up period. Male gender and baseline masked 
hypertension were found to be independent risk factors 
for developing sustained hypertension. Girls with undi-
agnosed masked hypertension may be at greater risk for 
developing sustained hypertension during pregnancy or 
while using OC20
Because estrogen is associated with increased epithe-
lial sodium channel proteins, it may limit the effect of 
the pubertal growth spurt on BP in girls, while in males, 
testosterone may exacerbate the effect of the growth 
spurt: BP has been reduced in a hypertensive mouse 
model (SHR/y) by use of either androgen receptor 
blockers or castration.81 In addition to the pubertal 
growth spurt, there are other complex physiological and 
hormonal changes during puberty that should not be 
ignored or underestimated. Leptin is positively corre-
lated with estrogen and negatively correlated with tes-
tosterone, and these factors account for the gender 
differences noted with changes in body composition and 
body fat percentages that occur during puberty.84 Early 
menarche occurs twice as frequently in girls with a BMI 
greater than the 85th percentile, and IR is common dur-
ing early puberty,35 with insulin sensitivity being nega-
tively correlated to body fatness, but unrelated to 
testosterone or estradiol.85
As with BP, there are also gender and racial differ-
ences in the prevalence of overweight/obesity and MetS. 
Based on the National Health and Nutrition Examination 
Survey (NHANES) 2001 to 2006 data,86 which did not 
evaluate NHA youth, the estimated overall prevalence 
of MetS in adolescents was 8.6%, with NHW at 8.9%, 
but the prevalence in NHB was much lower at 4.0%, 
while Hispanics had the highest rate at 11.2%. The prev-
alence of MetS in Hispanic boys (12.9%) and NHW 
boys (11.8%) was significantly higher than in Hispanic 
girls (9.4%) and NHW girls (5.8%), while the preva-
lence in NHB boys (3.9%) was slightly lower than for 
NHB girls (4.2%).86
In their 2011-2012 report,87 the Centers for Disease 
Control and Prevention (CDC) found that the overall 
prevalence of overweight and obesity in adolescents was 
34.5% with 14.0% classified as overweight and 20.5% 
classified as obese, but there were some significant dif-
ferences by race and gender. The overall prevalence in 
NHA was the lowest at 24.6%, with 13.5% being 
overweight and 11.1% being obese, but when considered 
by gender, the prevalence in NHA girls was 15.0% (7.7% 
overweight, 7.3% obese) while the prevalence in NHA 
boys was 33.9% (19.1% overweight, 14.8% obese). 
NHW overall rates were 31.2% with 11.6% overweight 
and 19.6% obese, while the prevalence in NHW girls 
was 31.0% (10.1% overweight, 20.9% obese) and the 
prevalence in NHW boys was 31.5% (13.2% overweight, 
18.3% obese).87
Hispanic overall rates were 38.1% with 15.5% over-
weight and 22.6% obese, while the prevalence in 
Hispanic girls was 36.5% (15.2% overweight, 21.3% 
obese) and the prevalence in Hispanic boys was 39.6% 
(15.7% overweight, 23.9% obese). NHB had the highest 
overall rates at 39.8% with 17.7% overweight and 21.1% 
obese, but the prevalence in NHB girls was 42.5% 
(19.8% overweight, 22.7% obese) while the prevalence 
in NHB boys was 37.3% (15.9% overweight, 21.4% 
obese).87 Consistent with other researchers,27,28,57,59 the 
CDC report87 cautioned that different sex, age, and race/
ethnicity groups may have different amounts of body fat 
or different distributions of body fat at the same BMI, 
and therefore may have different risks for obesity-
related diseases.
Genetic and Metabolic Influences
The most common indicator of metabolic changes 
related to obesity is IR, which can eventually result in 
development of T2DM and/or MetS, but blood sugar 
levels are often normal despite IR because higher 
amounts of insulin are secreted in response to impaired 
glucose metabolism.59,77 When IR is used as a screening 
criterion, significantly more children are diagnosed with 
MetS, and for this reason, homeostasis model assess-
ment of insulin resistance (HOMA-IR) is recommended 
as a better test for MetS in adolescents, instead of fasting 
glucose levels.59 Markers of IR include insulin sensitiv-
ity, elevated proinsulin and fasting insulin levels, 
impaired fasting glucose, and impaired glucose toler-
ance.62 Vitamin D enhances insulin sensitivity,88 and a 
meta-analysis of 8 longitudinal studies reported that the 
incidence of diabetes was 43% higher in those with 
serum vitamin D concentrations below 35 nmol/L when 
compared to those with concentrations greater than 62.5 
nmol/L.89
The bioavailable circulating form of vitamin D is 
serum 25-hydroxyvitamin D [25(OH)D], which is 
hydroxylated in the liver. It is converted to the active 
form, 1,25-dihydroxyvitamin D [1,25(OH)2D], by addi-
tional hydroxylation in the kidney, macrophages, 
and other cells in the body and plays a major role in 
calcium homeostasis and negative regulation of the 
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renin-aldosterone-angiotensin system (RAAS).89 There 
is an inverse relationship between vitamin D and RAAS 
activity, parathyroid hormone levels, coronary artery 
calcification, left ventricular hypertrophy (LVH), endo-
thelial dysfunction, hypertension, lipid dysregulation, 
platelet aggregation, stroke, and other CVD.89
A review of NHANES data from 2001 to 2006 found 
that vitamin D was also inversely related to HOMA-IR, 
SBP, WC, and prevalence of MetS.88 The prevalence of 
MetS in adolescents was 5.4% (6.9% in boys and 3.9% 
in girls), with 1.9% of those with a BMI below the 85th 
percentile having MetS, while 29.6% of those with a 
BMI at or above the 85th percentile had it.88 The preva-
lence of MetS was more than doubled (7.5% vs 3.5%, 
respectively) in those with a deficiency in 25(OH)D 
concentration (less than 50 nmol/L) when compared to 
those with sufficient 25(OH)D (at least 75 nmol/L), with 
girls, NHB, and those with the lowest SES being most 
affected.88 Another study found that ethnicity played a 
role in 25(OH)D deficiency, with concentrations below 
20 ng/mL in 54% of NHB, 47% of NHA, 41% of MA, 
and 26% of NHW subjects.90
Risk factors for low serum 25(OH)D concentration 
include obesity, dark skin, old age, indoor living, lack of 
exposure to sunlight, living at extreme north or south 
latitudes, genetic variations in metabolic pathways,89 
and vitamin D receptor polymorphisms.91 Vitamin D 
receptors are located on pancreatic β-cells, adipocytes, 
and inflammatory cells; there is a negative correlation of 
serum 25(OH)D concentration with β-cell dysfunction 
and IR,88,91 and a positive correlation with fatty acid 
metabolism88 and insulin sensitivity.90 In addition, there 
is an inverse association between serum 25(OH)D con-
centration and obesity, possibly due to increased storage 
of vitamin D in adipose tissue.88,92
A 2008 study70 found that NHW have less IR than 
Hispanics and NHB, who have similar rates of IR, and 
that both Hispanics and NHB respond to IR by increas-
ing secretion of insulin from pancreatic β-cells, but 
NHB also reduce insulin clearance through the liver, 
resulting in hyperinsulinemia. NHB are more likely than 
Hispanics to experience insulin-related cancers and 
much higher obesity-related hyperinsulinemia and insu-
lin-like growth factor 1 (IGF-1) concentrations, while 
Hispanics are more likely than NHB to experience non-
alcoholic fatty liver disease and T2DM resulting from 
β-cell failure.70 This study also found that NHB and 
Hispanics respond differently to increasing obesity, with 
IGF-1 concentrations increasing in NHB and decreasing 
in Hispanics. IGF-1 influences adipocyte proliferation 
and, with increasing adiposity, may result in an increased 
number of adipocyte cells in NHB, but an increased size 
of adipocyte cells in Hispanics. Larger adipocytes are 
more susceptible to cell death, resulting in lipid deposits 
in insulin-sensitive tissues such as the liver and are asso-
ciated with increased IR and development of T2DM.70
Other studies have found that NHA have a greater 
susceptibility to MetS and T2DM than NHW, indepen-
dent of adiposity,57 and that in obese Hispanic adoles-
cents, when compared to those without fatty liver, 
those with elevated liver fat had less insulin sensitiv-
ity, elevated HOMA-IR, more acute insulin response 
to glucose, and significantly higher concentrations of 
certain inflammatory markers.93 Another study sug-
gested that central adiposity among Hispanic youth 
may have less effect on BP than genetic polymor-
phisms, decreased vascular resistance, and higher 
renal sodium excretion rates.30
Clearly, genetic and racial heritage is associated 
with predispositions to IR, MetS, obesity, and hyper-
tension, and it may be the key to more effective treat-
ment strategies. Twin studies have shown that body 
weight and adiposity have a genetic basis, and molec-
ular genetics and neurochemistry have revealed the 
genetic mechanisms behind neurotransmitters and 
hormones (such as melanocort, adiponectin, leptin, 
ghrelin, growth hormone, and neuropeptide Y) that 
influence appetite, satiety, hunger, lipogenesis, lipoly-
sis, and fat distribution,32,35 but much work remains to 
fully understand these factors.
Research on genetic polymorphisms has found that 
they can be fairly straightforward or have complex 
effects. Variations in serum triglyceride and fibrinogen 
have been associated with polymorphisms in the lipo-
protein lipase gene and the fibrinogen gene, respec-
tively.94 A more complex but fairly common insertion/
deletion (I/D) polymorphism that has been widely stud-
ied in adults is the angiotensin I-converting enzyme 
(ACE) gene, which is an important regulatory agent in 
RAAS. One study found that low, intermediate, and high 
concentrations of circulating ACE were associated with 
II, ID, and DD genotypes, respectively, and explained 
47% of the variance in circulating ACE, but perhaps the 
most important finding was that the alleles had an addi-
tive effect, suggesting that they were codominant.95 This 
polymorphism has been associated with arterial hyper-
tension, obesity, coronary artery disease, and diabetic 
nephropathy in adults.94
A genetic polymorphism may explain the higher rate 
of masked hypertension in boys with a parental history 
of hypertension. A recent study94 of the ACE I/D poly-
morphism in obese youth reported a significant and 
independent D-allele effect in boys but not in girls 
between the ACE I/D polymorphism, arterial hyperten-
sion, and obesity-related traits, and these associations 
were not affected by other factors such as insulin 
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secretion, insulin sensitivity, or glucose tolerance. The 
presence of the D-allele in boys was found to be posi-
tively associated with higher BP, body weight, body fat 
mass, BMI, and WC, and had independent and additive 
effects with IR and body fat mass.94
The X-linked angiotensin converting enzyme-2 gene, 
which is highly expressed in renal and cardiac tissue, is 
thought to negatively regulate RAAS by increasing the 
concentrations of Angiotensin-(1-7), a vasodilator that 
modulates BP.96 A single nucleotide polymorphism in 
this gene was the focus of a longitudinal study in adoles-
cents that reported statistically significant differences by 
gender and ethnicity, with males and those of European 
ancestry being most affected, but with different effects 
on SBP and DBP depending on the single nucleotide 
polymorphism and gender.97 These gender-specific dif-
ferences in adolescents are significant because research 
has shown that testosterone stimulates RAAS activity, 
while estrogens have the opposite effect.94
On RAAS activation, vasoconstriction occurs, blood 
flow to the kidneys is reduced, sodium and water are 
retained, and BP rises. RAAS activity is stimulated by the 
sympathetic nervous system (SNS), which is thought to be 
stimulated by high concentrations of insulin and leptin, 
which are strongly associated with obesity.77 However, a 
study in Pima Indians,98 who have a low prevalence of 
hypertension despite high rates of obesity and hyperinsu-
linemia, suggests that there are ethnic differences in SNS 
stimulation and effects of obesity that need to be further 
explored. Hyperinsulinemia may be one mechanism that 
results in greater SNS activity leading to increased BP, but 
ethnic differences in β-adrenergic sensitivity, the effect of 
insulin on sodium excretion by the kidneys, and obesity-
related changes that affect structure and function in the 
cardiovascular and renal systems may be other mecha-
nisms that have effects on BP without SNS stimulation.98
Several studies have shown that BP is higher during 
winter months, and this may be due to seasonal varia-
tions in serum 25(OH)D concentration, which is a nega-
tive regulator of RAAS.99-101 Another mechanism may 
be hyperuricemia, which is strongly correlated with 
hypertension and appears to have both short-term and 
long-term effects on it: hyperuricemia initially activates 
RAAS and reduces endothelial nitric oxide synthesis, 
resulting in (uric acid-dependent and reversible) vaso-
constriction and elevated BP, and then plays a central 
role in renal afferent arteriolosclerosis, resulting in 
decreased renal blood flow and glomerular filtration 
rate, increased secretion of renin, and a (uric acid-inde-
pendent and irreversible) shift in urinary excretion of 
sodium and sodium-sensitive hypertension.102
Hypertension and MetS have been correlated with 
serum uric acid concentrations in adolescents and are 
predictive of cardiovascular events in adults, even when 
concentrations are within the normal range.103 Studies of 
hyperuricemia in children have reported that a serum 
uric acid concentration of at least 5.5 mg/dL had a speci-
ficity of 86%, a sensitivity of 87%, and an 82% positive 
predictive value for primary hypertension4 and that 
those with concentrations of at least 5.5 mg/dL were 
twice as likely to have elevated BP than those with con-
centrations below 5.5 mg/dL.104 Another study in ado-
lescents reported hyperuricemia (greater than 8.0 mg/
dL) in 9.5% of normotensives, 43% of prehypertensives, 
and 73% of those who had moderate or severe hyperten-
sion.105 The obese have a 3-fold higher risk of elevated 
serum uric acid, but hyperuricemia can also result from 
genetic polymorphisms in anion transporter genes, small 
bowel disease, kidney disease, or excessive consump-
tion of seafood, fatty meats, alcohol, and high-fructose 
corn syrup, as well as medications and diuretics that 
affect uric acid clearance by the kidneys.102
In a multi-ethnic study, mean serum uric acid concen-
trations were significantly elevated in children with pri-
mary (6.7 ± 1.3 mg/dL) and secondary (4.3 ± 1.4 mg/dL) 
hypertension when compared to children with white 
coat hypertension (3.6 ± 0.7 mg/dL).4 Hemoglobin was 
significantly higher in children with primary hyperten-
sion (14.6 ± 1.3 g/dL) when compared to children with 
secondary (12.8 ± 1.6 g/dL) or white coat (12.5 ± 1.2 g/
dL) hypertension, and when serum uric acid concentra-
tions exceeded 6 mg/dL, average hemoglobin levels 
were 15.4 ± 1.4 g/dL.102 These results suggest that 
hemoglobin and uric acid, if used in conjunction with 
OBP and ABP, may be useful markers for improving 
diagnosis of primary hypertension.
In addition to its role in BP homeostasis, RAAS also 
plays a role in weight regulation that is not fully under-
stood, but it is known that RAAS acts in adipocytes, that 
RAAS activity is positively correlated with body weight 
and body fat mass, and that reduced RAAS activity is 
associated with weight loss.94 Adipocytes are the pri-
mary producers of reactive oxidative species (ROS), 
which are associated with increased inflammatory mark-
ers such as tumor necrosis factor-α (TNF-α), interleu-
kin-6 (IL-6), plasminogen activator inhibitor, and 
adipocytokines.106 In addition to ROS, adipocytes 
secrete proteins such as leptin, adiponectin, resistin, and 
retinol binding protein-4, which play important roles in 
metabolism; some may also be markers for MetS.59
Obesity results in higher production of ROS and 
increases oxidative stress, which has been associated 
with increased risk of IR, T2DM, endothelial dysfunc-
tion, atherosclerosis and other CVD, as well as reduced 
antioxidant protection, increased lipid peroxidation, 
fatty liver, hypertension, hyperglycemia, and chronic 
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low-level inflammation.106,107 Obesity affects the distri-
bution of zinc in the body, resulting in low circulating 
zinc, which may disrupt membrane signaling involved 
in hormone regulation and contribute to IR.108
Obesity is also associated with reduced adiponectin; 
adiponectin protects against T2DM by increasing insu-
lin sensitivity and glucose metabolism, and is an anti-
inflammatory agent that protects endothelial function 
and prevents atherogenesis.77 The association between 
obesity and leptin is noteworthy: one study found sig-
nificantly higher leptin in overweight and obese children 
than in normal weight children (19.70 ng/mL vs 5.85 ng/
mL, respectively), and leptin concentrations were 
strongly correlated with increased heart rate as well as 
SBP and DBP percentiles.23 Another study reported that 
hyperleptinemia has been demonstrated to cause sus-
tained increases in BP.109
Just as there is a significant effect of adiposity on BP, 
which may be mediated by leptin, obesity may also affect 
renin and aldosterone concentrations, but there are some 
differences associated with racial heritage. A prospective 
study of NHB and NHW children and adolescents ana-
lyzed the effect of obesity on plasma aldosterone concen-
tration (PAC), plasma renin activity (PRA), and 
aldosterone-renin ratio (ARR), known as the renin-aldoste-
rone axis.110 This study found that ARR was slightly lower 
and PRA and PAC were statistically significantly lower in 
NHB than in NHW when smoothed for age and BMI. In 
addition, at all ages, PAC increased with BMI in NHW and 
PRA decreased with BMI in NHB, while both PAC and 
PRA were lower on average in NHB than in NHW. 
However, SBP was higher in NHB with lower PRA, higher 
PAC, and higher ARR; lower PRA has been associated 
with greater extracellular fluid volume, which may explain 
the higher SBP found in the NHB participants.110
The effect of obesity on the renin-aldosterone axis 
may explain the results of a study of NHB adults,111 
which reported that both SBP and DBP were signifi-
cantly correlated with serum cholesterol and anthropo-
metric measures such as BMI, WC, waist/hip ratio, and 
percent body fat in normotensive subjects, but in 
untreated hypertensive subjects, no significant correla-
tions were found with either serum cholesterol or anthro-
pometric measures. Conversely, WC was found to be 
predictive of SBP in untreated hypertensives, but not in 
those with normal BP.111 If obese NHB have greater 
fluid volume due to greater sodium reabsorption in the 
kidneys, this could increase BP sensitivity to adipos-
ity.110 Salt sensitivity is known to be associated with low 
PRA and has also been associated with lower hemoglo-
bin and even slower breathing rates.112
The normal mechanism for BP control is a feedback 
loop called pressure natriuresis, wherein increased 
renal perfusion pressure results in increased sodium and 
fluid excretion, followed by lowered BP. The set-point 
for BP regulation through this mechanism is sodium 
balance, where sodium intake and sodium output are 
equal. Research has shown that hypertension may be 
the result of a permanent shift in renal pressure natri-
uresis that initiates and then sustains chronic hyperten-
sion, driven by maintenance of sodium balance, and 
that excess weight gain may contribute to the impair-
ment of pressure natriuresis through increased com-
pression of the kidneys by the excess adipose tissue.109 
Sodium balance is not the only mechanism that regu-
lates BP, however; serum calcium also influences 
hypertension, possibly through its role in vascular 
smooth muscle contractility, and possibly through sig-
naling pathways for secretion and action of hormones 
that regulate and control BP and homeostasis.13
Salt-sensitive hypertensive patients with low renin 
concentrations have lower serum ionized calcium con-
centrations and higher 1,25(OH)2D concentrations; 
these patients appear to have a “calcium deficiency” 
calcium-metabolic profile. The opposite is found in salt-
insensitive hypertensives: they have high renin concen-
trations, higher serum ionized calcium concentrations, 
and lower 1,25(OH)2D concentrations, with an apparent 
“calcium excess” calcium-metabolic profile. These 2 
distinct calcium-metabolic profiles, low renin/low 
serum ionized calcium and high renin/high serum ion-
ized calcium, have different RAAS effects, may result 
from different calcium-regulating hormone concentra-
tions, and have increased and blunted responses, respec-
tively, to dietary sodium and calcium intake.113
Serum calcium has been positively correlated with 
BP in adults, independent of race/ethnicity, age, gender, 
BMI, or serum 25(OH)D concentration.114 Calcium is 
required for proper β-cell function and insulin secretion 
and plays an important role in insulin receptor sensitiv-
ity and glucose uptake by cells.115 A study in adolescents 
reported that those with serum calcium in the highest 
quartile (at least 2.53 mmol/L) had twice the prevalence 
of hypertension as those in the lowest quartile (no more 
than 2.37 mmol/L).13 Another study found that those 
with serum calcium in the highest tertile had greater 
fasting glucose and greater insulin resistance than those 
in the lowest tertile.115
There is also an inverse relationship between circu-
lating 1,25(OH)2D and serum calcium concentrations 
and a significant and inverse relationship between 
dietary calcium intake and body fat.116 Higher concen-
trations of 1,25(OH)2D have been found to signifi-
cantly stimulate calcium uptake in adipocytes; calcium 
influx inhibits lipolysis and stimulates lipogenesis and 
fatty acid synthase expression and activity.116 
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Conversely, increased dietary calcium suppresses 
serum 1,25(OH)2D concentrations, resulting in less 
lipogenesis and greater weight loss, even without cal-
orie restriction.116 NHB have the lowest dietary cal-
cium intake and the highest prevalence of obesity; a 
study evaluating calcium as an antihypertensive in 
obese NHB noted that increased dietary calcium intake 
resulted in reduction in body fat.116
Dietary Influences
In humans, dietary calcium from dairy sources is 50% to 
100% more effective for weight and fat loss when com-
pared to calcium carbonate supplements or calcium-for-
tified cereal.116 Studies in mice showed that those fed a 
low-calcium diet had reduced lipolysis, increased lipo-
genesis, and significant increases in body weight and fat 
mass, but when placed on a high-calcium diet, had a 3- 
to 5-fold increase in lipolysis, 51% reduction of lipogen-
esis, and 26% to 39% reduction in body weight and fat 
mass, with greater effects derived from dairy sources.116
There are few vitamin D supplementation studies in 
obese adolescents. One study reported that, at 2,000 
international units (IU) per day of vitamin D3 intake 
over 3 months, only 59% of obese youth achieved an 
increase in serum 25(OH)D concentrations when com-
pared to nonobese youth, with serum 25(OH)D concen-
trations reaching adequate levels in 89% of nonobese 
youth but in only 50% of obese youth.117 Another study 
found that 4000 IU per day of vitamin D3 supplementa-
tion over 6 months resulted in significant improvements 
in insulin resistance and insulin sensitivity, similar to 
metformin results, and independent of body weight.92 
This study reported that leptin was reduced by 15.6% 
and adiponectin was increased by 3.6% in the group 
receiving vitamin D3 supplementation; leptin regulates 
insulin secretion and increases glucose uptake, and adi-
ponectin increases insulin sensitivity, but these results 
were only seen after 6 months of supplementation.92 
These results suggest that long-term vitamin D3 supple-
mentation may be of significant benefit for obese youth, 
but both studies concluded that obese youth require 
greater amounts of vitamin D3 supplementation than 
nonobese youth, due to sequestration of vitamin D in 
adipocytes.
Vitamin D supplementation has been shown to improve 
hypertension, although the reductions were small,89 but 
dietary calcium was found to be negatively correlated with 
hypertension,114 and dairy sources of calcium were twice 
as effective and more consistently effective on BP than 
nondairy supplements.116 Those who are low renin/salt-
sensitive have a greater response to calcium intake than 
those who are high renin/salt-insensitive, and higher 
dietary salt intake may actually lower BP more for salt-
sensitive hypertensives taking calcium channel block-
ers.113 Salt-sensitivity has been associated with low birth 
weight, physical activity, genetic factors, renal disease, 
obesity, and NHB racial heritage, but the effect of salt on 
BP varies between individuals, with about half of hyper-
tensives, but only 25% to 33% of normotensives, being 
salt-sensitive.118
A review of NHANES 2003 to 2008 data reported 
that salt intake in children aged 8 to 18 averaged 8.5 
grams per day (3.4 grams of sodium per day), and even 
though sodium intake was significantly lower in over-
weight or obese adolescents, it had a much greater effect 
than in normal weight youth.118 An increase of just 1 
gram of sodium intake per day profoundly increased the 
risk of prehypertension and hypertension in overweight/
obese youth compared to normal weight youth (74% vs 
6%, respectively).118 A review of NHANES 1988 to 
2008 data reported a 36% increase in risk of elevated BP 
for children with sodium intake exceeding 3450 mg 
compared to intake of less than 2300 mg, after adjust-
ment for age, gender, race, BMI, and WC, and that BMI, 
WC, and sodium intake were independently associated 
with prevalence of higher BP.119 In the United States, 
more than 65% of sodium consumption is due to sodium 
enrichment of prepared foods such as cheese, breads, 
and cereals, whereas in developing countries, sodium 
intake is primarily from addition to food during cooking 
or at table, for example, from soy sauce.118
Soft drinks are an additional source of dietary sodium, 
as well as caffeine and sugar; sugar-sweetened (regular) 
sodas are a major source of dietary added sugars, pri-
marily from high-fructose corn syrup, and are strongly 
correlated with the development of excess weight in 
children and adolescents.120 However, the United States?
Department of Agriculture estimates that only one 
third of sugar consumption comes from soft drinks, 
with the remainder from fruit drinks, candies, bakery 
products, and dairy desserts.121 A cross-sectional anal-
ysis of NHANES 2003 to 2006 food questionnaire data 
reported that the average adult fructose consumption 
was 74 g/day (the amount contained in 2.5 regular soft 
drinks), with 50% of the study cohort consuming at 
least this amount per day.121 This study found that 
intake at or above 74 g/day was associated with 
increased risk of elevated SBP, with a 36% greater risk 
for those with SBP between 140 and 159 mm Hg, and 
more than double the risk for those with SBP of at least 
160 mm Hg, independent of kilocalorie intake, sodium 
intake, or weight.121
In a large ethnically diverse study of children and 
adolescents, regular soda consumption more than dou-
bled between the ages of 13 and 18, from 30% to 62% in 
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girls and 73% in boys.120 In one study, chronically 
increased consumption of high-fructose corn syrup 
resulted in chronically high serum uric acid and consis-
tently elevated BP,102 but another study found a strong 
correlation between fructose intake and higher SBP, 
independent of serum uric acid concentrations.121 The 
effect on SBP may be due to decreased excretion of uri-
nary sodium and/or increased sodium intake,103 and 
fructose research in animals indicates that there may be 
several mechanisms involved in elevation of BP, includ-
ing increased absorption of sodium in the intestine, stim-
ulation of the SNS and/or uric acid production, or 
inhibition of endothelial nitric oxide production.121
Even small amounts of fructose when regularly con-
sumed can have a significant impact; daily intake of just 
12 ounces of regular soda or other sugar-sweetened 
beverages (SSB) increases the risk of obesity by 60% 
and is associated with regular consumption of other 
unhealthy foods,120 and those with a higher SSB intake 
also have an increased likelihood of smoking and drink-
ing alcohol.103 An analysis of NHANES data from 1999 
to 2004 found that 82.5% of adolescents consumed SSB 
daily, with over 45% consuming more than 24 ounces, 
and over 27% consuming more than 36 ounces per 
day.103 Consumption of SSB was positively correlated 
with total kilocalorie, sodium, and caffeine consump-
tion; negatively correlated with consumption of milk 
and diet beverages; and higher in adolescents who were 
older and male.103
Other Controllable Influences
While the effects of dietary factors like sugar, sodium, 
and caffeine intake may seem fairly obvious, there are 
other less obvious influences on health during adoles-
cence. A large study of 17 year olds reported a signifi-
cant positive association between SBP, male gender, 
alcohol consumption, and OC use in girls, independent 
of BMI or dietary patterns.83 In this study, a significant 
positive correlation was found between higher SBP and 
alcohol consumption in boys but not girls, with a stron-
ger association found in heavy or binge drinkers; girls 
using OC had both higher SBP and DBP than girls not 
using OC; and increasing BMI had a significantly 
greater effect on SBP in boys than in girls.83
Another less-than-obvious but important influence is 
sleep quality and duration. Sleep duration refers to the 
difference between bedtime and wake-up time,122 and 
sleep quality refers to sleep efficiency or the percentage 
of time in bed spent asleep.123 Sleep duration studies in 
adolescents have reported that elevated BP was signifi-
cantly associated with alcohol consumption in younger 
adolescents,122 and that shorter sleepers were more 
likely to experience nocturnal nondipping, higher 
24-hour ABP, and a higher BP classification.123 A longi-
tudinal study of sleep duration and BMI found a strong 
association between shorter sleep and higher BMI in 
boys but not in girls, with the greatest effect of short 
sleep found in younger adolescents.124
Short sleep duration is thought to lower leptin con-
centrations and increase appetite; when combined with 
testosterone’s stimulatory effect on body mass, it is per-
haps not surprising that there is a greater effect on BMI 
in boys, whereas the increased leptin concentrations in 
adolescent girls protects from the leptin-reducing effects 
of sleep deprivation, and there is less impact on 
BMI.84,124 In a study focused on adolescent sleep dura-
tion and macronutrient intake, weeknight sleep duration 
ranged from 4.3 to 11.0 hours, with the average being 
7.55 hours.125 This study found that only about one third 
of adolescents achieved the recommended amount of 
sleep, which is 9 hours per night, and that shorter sleep 
duration was associated with increased snacking and 
greater appetite for high-fat, high-carbohydrate foods, 
resulting in an increase in caloric intake of nearly 500 
kilocalories per day.125
Another adolescent study found that weeknight sleep 
duration averaged 7.71 hours, that both short sleep dura-
tion and low sleep efficiency were twice as common in 
prehypertensives when compared with normotensives, 
and that those with sleep efficiency of 85% or less were 
3.5 times more likely to have prehypertension or hyper-
tension, independent of gender or adiposity and after 
adjustment for sleep duration.126 In both adults and ado-
lescents, shorter sleep duration has been associated with 
impaired glucose tolerance, metabolic and endocrine 
dysfunction, and increased risk of obesity.126 In adult 
studies, SDB and sleep apnea affected BP via SNS acti-
vation, while short sleep duration resulted in elevated 
BP, increased SNS activity, and reduced insulin sensitiv-
ity, and was associated with renal impairment and 
increased risk of CVD.127
A recent large study in adolescents found that they 
also face increased cardiovascular risk from inadequate 
sleep; however, poor sleep quality seemed to have a 
greater effect than short sleep duration.128 Short sleep 
duration was associated with greater consumption of 
caffeinated drinks and sodas, increased screen time, 
and less physical activity, while poor sleep quality was 
associated with these factors plus increased consump-
tion of fried foods, sweets, and other high-energy foods 
and snacks. This study concluded that poor sleep qual-
ity was associated with increased cardiovascular risk 
(defined as BMI exceeding the 85th percentile, higher 
cholesterol, and/or elevated BP), but that short sleep 
duration was not.128
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A more obvious influence on adolescent health is 
exercise. Gender differences in adolescent exercise rates 
were found in a review of studies based on the nationally 
representative Youth Risk Behavior Surveillance 
(YRBS) surveys from 1991 through 2007, which 
reported that only 43.7% of boys and 25.6% of girls 
achieved recommended amounts of physical activity 
(PA).129 The national average of youth who achieved the 
recommended amount of PA was 34.7%, but there were 
racial/ethnic differences as well, with 37.0% of NHW, 
31.1% of NHB, 30.2% of Hispanics, and 32.4% of 
Others achieving this amount of PA.129
Recommended PA is defined in the YRBS surveys as 
any activity that increases the heart rate and makes the 
participant breathe hard for at least 60 minutes per day 
on at least 5 of the previous 7 days; sufficient vigorous 
PA is defined as activity that increases the heart rate and 
makes the participant breathe hard for at least 20 min-
utes on at least 3 of the previous 7 days; and sufficient 
moderate PA is defined as activity that does not increase 
the heart rate or make the participant breathe hard for at 
least 30 minutes per day on at least 5 of the previous 7 
days.129 The minimum daily exercise recommended for 
children by the Institute of Medicine is at least 60 min-
utes to maintain healthy weight and 90 minutes for 
weight loss, while an analysis of PA intervention studies 
done in children recommended moderate intensity aero-
bic PA (defined as 70% to 80% of maximal fitness) for 
at least 40 minutes on at least 5 days each week to lower 
BP and improve vascular function in obese children.130
The analysis of YRBS data found that sufficient vig-
orous or moderate PA was basically unchanged (from 
65.8% to 64.1%, and from 26.7% to 26.5%, respec-
tively), daily physical education (PE) attendance and PE 
exercise duration increased significantly (from 25.4% to 
30.3%, and from 69.7% to 84.0%, respectively), while 
television viewing of at least 3 hours per day decreased 
significantly (from 42.8% to 35.4%).129 Although PA 
decreased and sedentary behaviors increased with age in 
adolescents, inactivity was greatest in older girls and 
minorities.129 Importantly, this study concluded that 
although recommended PA amounts were not achieved, 
activity levels among United States youth did not change 
sufficiently to support the common belief that the recent 
increase in obesity in United States adolescents is due to 
increased sedentary behaviors and reduced PA.129
Exercise programs for overweight or obese adoles-
cents have reported that even modest reductions in 
weight resulted in statistically significant improvements 
in BP, dyslipidemia, and IR.79,130 Similarly, in adults, 
regular PA and cardiorespiratory fitness (fitness) have 
been associated with reduced risk of obesity, hyperten-
sion, and other chronic diseases,130,131 and even a weight 
loss of 5% to 10% from baseline has been found to be 
effective in lowering BP, independent of sodium 
intake.131 Several studies in adults investigated the pos-
sible mechanisms involved in the reduction of BP con-
current with weight loss, such as lower blood volume 
and/or cardiac output, suppression of the SNS, reduced 
RAAS activation, and less IR, and found that lower nor-
epinephrine and PRA and improved insulin sensitivity 
were predictors for lower BP after weight loss.131
A review of the published research on PA and high 
BP in children reported lower SNS activation in normo-
tensive obese individuals when compared to obese indi-
viduals with high BP, greater IR in normal weight 
hypertensives as well as obese hypertensives when com-
pared with normotensive BMI-matched peers, and 
reduced serum norepinephrine concentrations following 
weight loss.130 Transgenic research has revealed that 
hyperinsulinemia and regulation of MAP can be uncou-
pled, indicating they may share similar pathways that 
are affected by weight gain, and perhaps explaining why 
they so often appear together and respond in a similar 
manner to weight gain or loss.130 Surprisingly, studies of 
high BP in overweight children found that the mecha-
nisms were greater resting cardiac output and increased 
stroke volume, rather than higher systemic vascular 
resistance, and the reduction in SBP was correlated with 
slower heart rate in response to increased PA.130
Improved fitness should be one of the desired out-
comes of any PA intervention focused on weight loss, 
but improved fitness and the associated health benefits 
are possible whether significant weight loss occurs or 
not. A recent large study found that improvements in fit-
ness (as measured by estimated oxygen consumption) 
significantly reduced MAP in overweight and obese 
children, and there was a greater reduction in MAP in 
obese/fit than in overweight/fit youth.132 This is a sig-
nificant finding, because although MAP was elevated in 
only 15% of the study participants overall, 36% of 
obese/unfit participants had elevated MAP, and while 
only 23% of the total study participants were found to be 
unfit, just 16% of normal weight participants were unfit, 
whereas the prevalence was much higher in the over-
weight and obese participants, with 35% and 63%, 
respectively, being classified as unfit. When compared 
to normal weight/fit peers, the risk of elevated MAP was 
higher for boys than girls, but greater fitness signifi-
cantly improved this risk for both genders: in males, the 
risk decreased from 4.28 in obese/unfit to 1.93 in obese/
fit, and in females, the risk was reduced from 3.39 in 
obese/unfit to 1.64 in obese/fit.132
A recent study found that youth with a higher SES, 
nonminorities, and those with a lower weight status 
were more physically active than youth who were 
Ewald and Haldeman 17
low-income, ethnic minorities, or those with a higher 
weight status; however, higher weight status had an 
inverse influence on PA levels, regardless of other fac-
tors such as motivation or emotional support.133 This 
study reported that an increase in motivation correlated 
with an increase in PA in those who were normal 
weight, and therefore could be an effective obesity pre-
vention strategy, but in those who were already over-
weight or obese, increased motivation actually resulted 
in decreased PA.133
Two extensive literature reviews of PA interventions 
in adolescents found that a variety of exercise types, 
duration, intensity, and frequency were used, some in 
combination with diet and/or lifestyle changes, and the 
results were understandably inconsistent at best and left 
many unanswered questions.130,134 Results of interven-
tion studies suggest that increased PA is associated with 
lowered BP and improved fitness, but unfortunately, 
physiological improvements achieved during the studies 
returned to baseline within a few months after the stud-
ies concluded.79,130 This is consistent with a meta-analy-
sis of 64 obesity prevention programs for adolescents, 
which found that while 13 (21%) were successful from 
pretest to posttest, similar to prevention programs for 
eating disorders, smoking cessation, and substance 
abuse, only 3 (5%) were successful over a significant 
follow-up period.135
Changing maladaptive health behaviors is inherently 
difficult, and increasing PA in overweight and obese 
adolescents has proven to be challenging, so it is unreal-
istic to expect that these adolescents can successfully 
manage weight loss without significant support. This is 
underscored by the fact that between 1999 and 2008 the 
prevalence of youth with extreme obesity increased, 
while the prevalence of overweight and obese youth 
remained virtually unchanged.26,136 The epidemic of 
excess adiposity and the prevalence of undiagnosed and 
untreated hypertension among children and adolescents 
are creating a public health crisis with lifelong conse-
quences for the children and staggering healthcare and 
socioeconomic costs.
Improving Diagnosis and Treatment 
Outcomes
The High Cost of Hypertension and Obesity
There is growing public awareness of the health conse-
quences of excess weight, such as the probability of 
developing hypertension, CVD, T2DM, MetS, or 
chronic kidney disease (CKD) in the future,10,27,28,31 but 
this knowledge has not led to substantial weight loss in 
children or adolescents.26,136 Although about half of 
hypertensive adolescents are also obese,24 childhood 
hypertension occurs even without excess adiposity, and 
is frequently undiagnosed and untreated.2,7 Perhaps 
because the small and seemingly inconsequential 
changes in blood lipids, BP, glucose metabolism, and 
blood sugar concentrations, and less obvious physio-
logical changes such as arterial stiffness, inflamma-
tion, atherosclerosis, and endothelial dysfunction,26 
occur so gradually, these early warning signs are easy 
to ignore or miss altogether in overweight and moder-
ately obese children,7 and are rarely checked for in 
MONW children.57
By the time these changes are significant enough to 
cause concern, measureable and permanent organ dam-
age has often occurred,23 including increased heart 
mass, LVH, increased thickness of the carotid artery 
wall, narrowing of the arteries in the kidneys and retina, 
and impaired vascular functionality due to calcification, 
atherosclerosis, and arterial stiffening.10,26 LVH is the 
most common type of organ damage associated with 
hypertension, with 50% of hypertensive children hav-
ing enlargement that exceeds the 90th percentile, and 
14% having enlargement that exceeds the 99th percen-
tile.10 The severity of obesity and hypertension is 
directly correlated with the degree of increased heart 
mass and LVH, which predict future development of 
congestive heart failure.77 Nonalcoholic fatty liver dis-
ease is also common, occurring in up to 77% of children 
aged 2 to 19, with greater prevalence by age and obesity 
status.70,77
Impaired vascular functionality may include 
impaired cerebrovascular reactivity, with associated 
neurocognitive implications.137 Studies of hyperten-
sive adults have found decreased neurocognitive per-
formance and evidence of possible heritability of 
cognitive defects in normotensive adult children of 
hypertensive parents, and recent studies of hyperten-
sive children have found neurocognitive and behav-
ioral impairments when compared to normotensive 
controls, with hypertensive children having a 4-fold 
greater likelihood of being diagnosed with a learning 
disability or attention deficit-hyperactivity disorder.137 
It is not yet clear whether hypertension and associated 
cerebrovascular remodeling result in cognitive impair-
ment, or whether structural changes in the brain under-
lie both increased BP and decreased cognitive 
performance.137
Cognitive impairment and structural changes in the 
brain were also seen in obese adolescents with MetS but 
without T2DM: of the 5 markers used to classify a child 
with MetS, only IR was significantly correlated with 
smaller hippocampal size and larger volume of cerebro-
spinal fluid, independent of age, gender, and degree of 
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obesity.138 Although still within normal parameters, 
those with MetS scored significantly lower on spelling, 
arithmetic, attention, and mental flexibility assessments 
and had lower estimated IQ, and as the number of MetS 
markers present increased, greater impairment in cogni-
tive performance was seen; similar but more pronounced 
cognitive impairments and reduced hippocampal vol-
ume have been seen in obese adolescents and adults 
with T2DM.138
These findings provide preliminary evidence that 
obesity and/or hypertension are sufficient to impair neu-
rocognitive function, that metabolic dysregulation 
affects brain structure, and that these effects are present 
much earlier in the progression of these diseases than 
had been thought.137,138 Given the high degree of track-
ing from adolescence into adulthood for obesity, hyper-
tension, CVD, T2DM, and MetS, and the health 
consequences and socioeconomic impact of these condi-
tions,26,35,73,139 these neurocognitive findings should be 
of great concern. It is not known whether improvement 
in MetS parameters, hypertensive status, or degree of 
obesity will reverse these changes, and it is difficult to 
measure the impact of these impairments on future aca-
demic and professional progress, earning potential, and 
quality of life.
Youth with extreme obesity face additional medical 
consequences as well, including gallstones, which may 
require surgical removal; polycystic ovary syndrome, 
which increases risk of infertility and MetS; cirrhosis of 
the liver, requiring liver transplant; slipped capital femo-
ral epiphysis, requiring surgery to repair the fracture; 
pseudotumor cerebri, which can lead to permanent loss 
of vision if intracranial pressure is not relieved; severe 
degenerative joint disease, which can severely restrict 
movement; premature heart disease; and premature 
death.26,77,136 Not surprisingly, body mass alone can 
impair mobility and prevent the extremely obese from 
independently performing activities of daily living or 
engaging in exercise.
The foregoing physical and medical consequences 
of adolescent hypertension and obesity are serious. 
Equally serious but perhaps less well-recognized are 
the psychosocial consequences, which include anxiety, 
depression, eating disorders, psychiatric disorders,136 
high-risk behaviors, impaired psychosocial function-
ing, and reduced quality of life.76,77 Those with extreme 
obesity also experience these consequences, but the 
severity and prevalence are greater; for example, clini-
cally significant depression was reported in 30% and 
clinical binge-eating was reported in 67% of extremely 
obese adolescents who sought treatment.26 In addition, 
severely obese adolescents face social isolation and 
high levels of unemployment due to functional 
impairment and stigmatization, and very few seek med-
ical treatment for their obesity.136
Interventions
The single most effective way to prevent or reduce 
hypertension in adolescents is to measure height, weight, 
BP, and WC, and calculate BMI %, for every child, 
every year, in every school grade, so that early signs can 
be followed up and corrective measures can be taken 
before organ damage occurs. As the literature has shown, 
conventional practices are not all-inclusive; many health 
care screenings do not include BP measurements for 
children, and BMI is rarely calculated or used unless the 
child is already obese. These simple screening measure-
ments could be incorporated into existing school or 
community programs, and should include children who 
have little or no access to regular health care, such as 
low-income, immigrant, and minority youth, who are 
most at risk for and most affected by hypertension and 
obesity. Early intervention and preventive measures 
would reduce the number of children and adolescents 
who reach adulthood before they are diagnosed with 
hypertension.
Prevention is also the best strategy for reducing the 
incidence of overweight and obesity, and exercise for 
personal fitness should be emphasized in physical edu-
cation programs.35 Obese children should be evaluated 
for hypertension before beginning any exercise regi-
men.24 Interventions focused on preventing or minimiz-
ing further weight gain are needed, which combine the 
expertise of professionals in the fields of exercise physi-
ology, physical therapy, behavioral health, and nutrition 
as appropriate.35 Nutritional counseling to achieve 
weight loss is an important part of managing hyperten-
sion and obesity and should include family.24
Dietary interventions need to emphasize reduced 
intake of SSB, fruit-flavored drinks, and other foods 
containing high-fructose corn syrup, promote increased 
consumption of low-fat milk or 100% fruit juice, and 
provide calcium-rich alternatives for lactose-intolerant 
children.120 The sale of energy-dense, nutrient-poor 
drinks and snacks through school-based stores, vending 
machines, and snack bars should be reduced or elimi-
nated.35 Intervention strategies should focus on replac-
ing unhealthy selections with better-quality options in 
the home, school, and child care environments, model-
ing of healthy behaviors by parents and educators, and 
reducing children’s exposure to marketing that promotes 
unhealthy choices.120
Normal adolescent thought development includes 
fluctuations between concrete and abstract thinking, 
overconfidence (underestimation of difficulty in 
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changing behaviors, or oversimplification of barriers 
to progress), and hypersensitivity to being “different,” 
which can be exacerbated by teasing and bullying.140 
These unique developmental factors must be taken 
into consideration when designing interventions. 
Multidimensional behavioral modification approaches 
that include lifestyle, diet, and exercise components 
have been shown to result in significantly greater sus-
tained weight reduction in adolescents when compared 
to conventional programs that focus just on changes to 
diet or PA.45,79
Encouraging lifestyle and behavior modifications 
that incorporate more physical activity, develop healthy 
eating behaviors, and promote coping strategies for 
effectively dealing with stressors are especially impor-
tant during adolescence because lifelong diet and exer-
cise habits are established before adulthood is 
reached.76,141 The most successful programs also incor-
porate parental support and encourage parental model-
ing of desired healthy behaviors, thereby providing 
greater support for adolescents.26,79 Cognitive behav-
ioral approaches are particularly important for adoles-
cents who have anxiety or depression, to reinforce 
self-efficacy and coping skills and healthy lifestyle 
behavior choices.76
Although further research is needed to establish 
causal relationships, clinical screening and therapeutic 
strategies for adolescent girls should include psycho-
logical factors such as ineffectiveness, lack of interocep-
tive awareness, emotional eating, drive for thinness, and 
body dissatisfaction, which are all significantly corre-
lated with increased risk of weight gain.78 Interventions 
that rely on PA to prevent or reduce overweight and obe-
sity need to address the very low amounts of PA that are 
the norm for adolescent girls, particularly among NHB 
girls and those from low SES households.78 In addition, 
efforts to prevent or reduce childhood overweight and 
obesity in populations with psychosocial stressors need 
to include programs to help children learn how to cope 
effectively with these issues.35
Standard therapeutic approaches also need to be 
adapted to address additional issues that these popula-
tions face, such as differences in cultural backgrounds, 
language barriers, or perceptions of health and illness.45 
For example, different cultures have different beliefs 
about what constitutes a healthy or attractive weight,32 
and in some high-risk families, even extreme obesity is 
not perceived as a cause for concern.45 Higher psychoso-
cial risk factors (migration background, low SES, paren-
tal unemployment) or more extreme baseline obesity are 
correlated with significantly less access to and participa-
tion in therapeutic programs, and therefore significantly 
less weight loss.45
Overweight and obese youth may particularly benefit 
from behavioral weight control interventions that are 
specifically designed to increase self-efficacy, minimize 
embarrassment about physical appearance or ability, and 
can be modified as needed to accommodate body mass 
or deconditioning issues. Instead of competitive sports, 
which provide little opportunity for obese participants to 
excel, activities such as walking, dancing, or resistance 
training may prove to be more attractive alternatives that 
can reduce weight, increase strength, and improve health 
outcomes.141 Appropriately monitored youth with severe 
hypertension who want to engage in strength training 
exercises should start with more repetitions of lower 
weights until their BP is under control.24
The lack of long-term success in intervention pro-
grams may have been explained by a meta-analysis of 
the published literature pertaining to the effects of PA in 
overweight and obese adolescents,134 which found that 
the most common activities chosen for these interven-
tions were aerobic activities similar to those used with 
adults, such as running, circuit training, cycle ergometer 
exercise, or team games. These activities may have been 
chosen for ease of control and measurement of out-
comes, but were monotonous, boring, and uninviting for 
obese and overweight participants, and had not been 
adapted for the unique physical challenges facing these 
adolescents or to make them more interesting or enjoy-
able. Perhaps not surprisingly, none of the studies 
reported whether the participants enjoyed the PA activi-
ties, none reported on the adolescents’ satisfaction or 
compliance with the PA program, and most did not 
report the dropout rates from their PA interventions.134
In adolescents, exercise plus calorie restriction and 
behavior change had a greater effect on lowering BP 
than just calorie restriction and behavior change; 
changes in MAP as a result of weight loss were corre-
lated with reduced visceral fat volume but not with 
changes in BMI or overall body weight, and were inde-
pendent of sodium reduction.131 Weight loss with orlistat 
was correlated with lower SBP and DBP, with greater 
effects seen in those who lost more than 10% of baseline 
weight.131 Modest weight loss of just 5% to 10% of 
baseline weight, even when ideal weight is not reached, 
can improve or normalize BP and insulin sensitivity and 
consequently prevent, reduce, or eliminate the need for 
medications, reduce the risk of T2DM and cardiovascu-
lar disturbances, and improve quality of life and psycho-
logical well-being.131
Increased moderate or vigorous PA, weight loss, and 
reduced sodium intake have been shown to be the best 
nonpharmacological approaches to preventing or reduc-
ing elevated BP, especially in children with excess adi-
posity.3,24,131 If these measures are not sufficient, 
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antihypertensives, such as ACE inhibitors, have been 
effective in reducing BP, reversing LVH, and reducing 
proteinuria and progression of CKD in hypertensive 
children. A 5-year study of children and adolescents 
with CKD reported that aggressively controlling MAP 
below the 50th percentile for BP decreased proteinuria 
and prevented progressive deterioration of kidney func-
tion.142 Antihypertensive medications used in conjunc-
tion with nonpharmacological therapies in children with 
an elevated cardiovascular risk profile, especially if 
T2DM is present, may be an option. Calcium antago-
nists, β-adrenergic blockers, and angiotensin receptor 
blockers have not been studied as extensively in chil-
dren, but appear to also be effective antihypertensive 
medications.3,24
There are very few medications approved for weight 
loss use in children and adolescents,26 and metformin is 
the only oral medication approved for use in children 
with T2DM 3. A meta-analysis of 5 studies of metformin 
in youth reported a BMI reduction of 1.42 kg/m2, but no 
studies have been done to determine if it will delay onset 
of T2DM, and studies have not been reported in adoles-
cents with severe obesity.26 Studies in obese youth of 
exenatide, which enhances glycemic control in T2DM, 
and orlistat, which blocks intestinal absorption of fats, 
have both reported mild to moderate gastrointestinal 
side effects, modest reductions in weight or BMI, and 
very little improvement in cardiometabolic risk fac-
tors.26 Only orlistat is approved for use in adolescents, 
but tolerability issues have limited its use.26
There may be another alternative for some children. 
Incretin-based therapies are already used for regulating 
blood sugar and management of T2DM and recent 
research has shown great promise for reducing hyper-
tension, although reduction of BP was not the primary 
goal of these studies.143 The incretin system is composed 
of 3 hormones: glucose-dependent insulinotropic poly-
peptide, glucagon-like peptide-1, and dipeptidylpepti-
dase 4, which promote insulin release, regulate satiety, 
and promote weight loss.143 Glucagon-like peptide-1 
receptor agonists such as exenatide and liraglutide, and 
dipeptidylpeptidase 4 inhibitors such as sitagliptin, are 
not antihypertensive drugs but were found to be effec-
tive in lowering BP independent of weight loss, and may 
play a role in reducing inflammation and oxidative 
stress, preventing RAAS overactivity, and protecting the 
kidneys and cardiovascular system.143 Incretin-based 
therapies are an area of intense research activity with 
great potential for improving health outcomes for dia-
betic, hypertensive, and obese adolescents.143
For extremely obese adolescents, there are very few 
good alternatives. Traditional weight loss approaches 
based on pharmacological interventions or the 
paradigm of increased PA and reduced calories have a 
high failure rate, and bariatric surgery is still in the 
experimental stage, although it has a high success 
rate.136 A German study is investigating the effective-
ness of an intervention program that focuses on improv-
ing psychosocial functioning, reducing social isolation, 
improving self-esteem, increasing employment, provid-
ing obesity-related education, and raising awareness of 
long-term consequences of obesity. This study will be a 
starting point for presurgery assessment of extremely 
obese adolescents who may then have the option of bar-
iatric surgery.136
While highly controversial, bariatric surgery for 
severely obese adolescents has proven to be much more 
successful than behavior-based weight management 
programs, with safety and weight-loss outcomes compa-
rable to adults and improvement or resolution of many 
of the associated conditions, such as hypertension, dys-
lipidemia, OSA, T2DM, MetS, pseudotumor cerebri, 
and psychosocial disorders.26 Much of the research has 
focused on roux en y gastric bypass (RYGB) and adjust-
able gastric banding, but recent small studies with lapa-
roscopic vertical gastric banding have reported 
comparable weight loss outcomes, fewer complications, 
and fewer nutritional risks than RYGB, although more 
research is needed to verify that vertical gastric banding 
is a safer alternative.26
With RYGB and adjustable gastric banding, BMI 
reductions of up to 37% have been reported in the first 
year postsurgery, compared to about 3% BMI reduction 
achieved by control groups following a behavior-based 
weight management program, and the long-term weight 
regain seen with the control groups was not seen with 
the postsurgery patients.26 However, bariatric surgery is 
not an option for many severely obese youth, either 
because they are too young, lack emotional maturity or 
family support, do not want it, or cannot afford it.26 
Because it has not been approved for use in adolescents, 
insurance reimbursement should not be expected.
Barriers
Lack of insurance coverage for prevention of over-
weight and obesity, weight management, and obesity 
care, and limited reimbursement for prevention, treat-
ment, and third-party services, are significant barriers 
for families and disincentives for physicians and other 
health care providers.35 A survey of pediatricians found 
that effective weight management efforts were ham-
pered by lack of insurance coverage for weight manage-
ment programs (69%) or dietitian services (more than 
50%), lack of referral services for their overweight 
patients (more than 50%), not having a dietitian or 
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nutritionist on staff (80%), inability to bill separately 
from well visits for overweight counseling and treat-
ment (85%), and insufficient insurance reimbursement 
for these services (56%).36
This survey of pediatricians also found that 67% did 
not have enough time for counseling about weight dur-
ing well visits, that most believed counseling had poor 
results, that only 23% believed there were good treat-
ments for overweight children, and that there was dis-
agreement about whether treatments were effective.36 
The biggest influence on behavior was that pediatricians 
felt helpless or skeptical that they could influence their 
patients’ weight status; this lack of self-efficacy may 
explain in part the low level of compliance with BMI 
and BP screening and treatment guidelines.36 Survey 
results showed that 92% of physicians were interested in 
preventing childhood overweight and obesity and half 
believed it was preventable, but only 59% believed that 
families wanted to discuss weight at well visits; despite 
this, 89% regularly discussed fruit and vegetable con-
sumption, 86% encouraged increased PA, and 76% sug-
gested reduced screen time.36
On a community scale, efforts to combat obesity 
and hypertension too often are hampered by competi-
tion for limited funding; lack of cooperation and col-
laboration between existing government agencies, 
community and grass-roots organizations, schools, 
businesses, and health care systems; and failure to 
develop culturally appropriate interventions that are 
designed for specific communities or at-risk popula-
tions.144 Eliminating food deserts, increasing access to 
healthy foods, encouraging community gardens, and 
providing lactation support are ways to prevent and 
reduce obesity and support healthy weight among at-
risk populations, but they require coordinated effort, 
long-term commitment, and skilled leadership.144
Low SES and minority adolescents face many barri-
ers to increasing PA, such as lack of gyms, athletic 
fields, or recreational facilities in their schools and local 
communities; lack of PA programs, coaches, or PE 
teachers; fewer role models; and lack of support from 
their parents and family.129 Local community and gov-
ernment agencies, schools, and public health profession-
als must work together to provide accessible and 
affordable facilities and programs, convenient public 
transportation, and safer streets and parks, so that stu-
dents have a supportive environment that encourages 
increased PA and development of active lifestyles.129
Government programs for improved childhood nutri-
tion and prevention of overweight and obesity have 
received public exposure but the prevalence and risks of 
pediatric hypertension are not as well known by the gen-
eral public. Development of comprehensive programs 
for prevention and treatment of pediatric hypertension 
are hampered by limited or lacking insurance reimburse-
ment of costs associated with investigation of long-term 
treatment options.3 Lack of funding for studies of pedi-
atric hypertension is a serious impediment to developing 
evidence-based recommendations for diagnosis and 
treatment; contributes to undiagnosed hypertension, 
undetected target-organ damage, and poor BP manage-
ment; and has serious long-term consequences for chil-
dren’s health.3
A Call to Action
This literature review indicates that controllable factors 
such as poor diet, reduced activity, increased stress, and 
sleep deprivation initiate or contribute to a certain degree 
of hormonal and metabolic changes. Eventually, these 
small incremental factors can play a significant role in 
dysregulation of homeostasis and are considered to be 
important influences on the development of obesity and/
or hypertension. The adage that “a calorie is a calorie” is 
touted to support the idea that the solution to obesity is 
simply to eat less and exercise more, but if it were that 
easy to manage weight, everyone would be able to do it 
and there would not be an obesity epidemic.
The fact that so many try but fail to lose weight or to 
keep it off has not been interpreted as a need for a new 
approach, but instead has led to the common perception 
that those who are overweight or obese are not moti-
vated to change.145-148 It is true that some overweight or 
obese adolescents have an eating disorder, and those 
children should be identified and given appropriate 
treatment. However, since many of the interventions 
that have been tried have proven to be less than effective 
in the long term, perhaps it is time to consider that the 
problem is with something other than the motivation of 
the participants.
This review has provided an abundance of evidence 
that gender, pubertal stage, genetics, and racial and cul-
tural heritage are factors that play a significant role in 
the development and severity of adolescent hyperten-
sion, overweight, and obesity. These factors are beyond 
the control of any individual, and therefore must be rec-
ognized and their influence must be incorporated into 
the development of effective treatment approaches, so 
that a one-size-fits-all model does not guarantee failure 
for the majority who try it.
The long-term effects of adolescent hypertension and 
obesity are quite profound and sobering, and this review 
has shown that the causes are multifaceted, complex, 
overlapping, and sometimes confounding. Defining 
obesity as a disease is a good beginning, and with that 
definition must come the understanding that, in many 
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cases, obesity is not the patient’s fault, just as hyperten-
sion is not. The lack of adequate insurance reimburse-
ment for prevention and treatment of overweight and 
obesity prolongs the epidemic. Funding for further 
research is needed to fully understand the causes of obe-
sity and hypertension, and to find interventions that are 
effective for those who struggle with these conditions. 
The self-perpetuating nature of these complex diseases 
requires that every effort be made to find solutions for 
the current generation of children and adolescents who 
will become the parents of tomorrow.
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